News

Biologicals dominate Europe’s best sellers

Published on 2015/03/18

The landscape of blockbuster medicines in Europe has been changing over the last years from small molecule drugs to biologicals. Biologicals now dominate the top 10 list of best-selling medic...

20 views

Read more →

Influence of CETA on generics

Published on 2015/03/16

On 18 October 2013, the European Union (EU) and Canada reached a political agreement on the key elements for a Comprehensive Economic and Trade Agreement (CETA). However, CETA has been criticized fo...

13 views

Read more →

ECCO position statement on biosimilars

Published on 2015/03/12

The European Crohn’s and Colitis Organisation (ECCO) is a non-profit association with the aim of improving the care of patients with inflammatory bowel disease (IBD) in Europe. The association cur...

120 views

Read more →

Factors influencing use of generic asthma drugs in Morocco

Published on 2015/03/10

Despite the introduction of methods to promote the use of generics, use of generic anti-asthmatic drugs remains limited in Morocco. The Moroccan market therefore remains largely dominated by patent-...

18 views

Read more →

EMA criticized for change in data transparency plans

Published on 2015/03/06

New Legislation approved by the European Parliament on 2 April 2014 aims to increase transparency with respect to clinical trials by making the results publicly available. The Clinical Trials Regula...

37 views

Read more →

Factors supporting a sustainable European biosimilars market

Published on 2015/03/04

Factors that will support a sustainable biosimilars market in Europe include education, encouraging competition, publication of real-world evidence and transparent decision-making processes, accordi...

34 views

Read more →

Can the pursuit of biosimilar interchangeability go too far?

Published on 2015/03/02

The question of biosimilar interchangeability – whether or not a biosimilar can safely be switched with another biosimilar or with the originator product – is a thorny one. In fact, write Hans C...

20 views

Read more →

Europe–Japan cooperation on generics and biosimilars regulation

Published on 2015/02/26

Japanese and European generics groups have met to discuss increase regulatory cooperation between the two regions. The Japanese Generic Medicines Association (JGA), the Nippon Keidanren (Japanese I...

24 views

Read more →

Top 8 blockbuster biologicals 2013

Published on 2015/02/24

The top three best-selling drugs during 2013 were biologicals. All three best-sellers are indicated for the treatment of arthritis, and include Abbott’s Humira (adalimumab), Merck’s Remicade (in...

31 views

Read more →

Impact of price cuts on spending on hyperlipidaemic drugs in South Korea

Published on 2015/02/20

Rapidly increasing pharmaceutical expenditures have become a constant challenge to the sustainability of healthcare systems across countries including Korea. Policies for pharmaceuticals can ...

33 views

Read more →

Brazil speeds up approval process for generics and biologicals

Published on 2015/02/18

Brazil’s National Health Surveillance Agency [Agência Nacional de Vigilância Sanitária, ANVISA] announced on 3 June 2014 the publication of a new guideline for generics and biologicals aimed at...

35 views

Read more →

The global biologicals market

Published on 2015/02/16

Global spending on medicines is expected to reach the US$1 trillion threshold in 2014 and rise to US$1.2 trillion by 2017. This increase is mainly attributed to greater access to medicines by...

19 views

Read more →